Shp2 as a therapeutic target for leptin resistance and obesity

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.10, Iss.1, 2006-02, pp. : 135-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein-Tyrosine Phosphatase 1B (PTP1B): A Novel Therapeutic Target for Type 2 Diabetes Mellitus, Obesity and Related States of Insulin Resistance

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 1, Iss. 3, 2001-11 ,pp. : 265-275

Bentham Science Publishers

Access to resources Recommend Favorite

DGAT: Novel Therapeutic Target for Obesity and Type 2 Diabetes Mellitus

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 263-270

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Leptin and the Cardiovascular System - A Target for Therapeutic Interventions

Current Pharmaceutical Design, Vol. 20, Iss. 4, 2014-02 ,pp. : 601-602

Bentham Science Publishers

Access to resources Recommend Favorite

Leptin-Induced Endothelial Dysfunction: A Target for Therapeutic Interventions

Current Pharmaceutical Design, Vol. 20, Iss. 4, 2014-02 ,pp. : 603-608

Bentham Science Publishers

Access to resources Recommend Favorite

TGR5 as a Therapeutic Target for Treating Obesity

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 4, 2010-03 ,pp. : 386-396

Bentham Science Publishers

Access to resources Recommend Favorite